Physician profile
Ebrahim Paryavi
NPI 1093982951
$896.48
in general payments reported to CMS, 2019-2025
8 companies · $63.84 in 2025
The $63.84 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2022: $189 · 2023: $38.04 · 2024: $112 · 2025: $63.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $271.36 | 2019-2024 | A.L.P.S., Bactisure, Activbraid |
| Axogen | $232.85 | 2019 | |
| Skeletal Dynamics INC | $104.19 | 2019 | |
| Depuy Synthes Sales INC. | $98.68 | 2024-2025 | Lcp, Unium, Fibergraft Bg Morsels |
| Kci USA, INC. | $93.25 | 2022 | |
| Ethicon US, LLC | $56.17 | 2023-2025 | Stratafix, Vistaseal, Dermabond Prineo |
| Stryker Corporation | $21.80 | 2022 | |
| Integra Lifesciences Corporation | $18.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ebrahim Paryavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.